Announcing the new QIAstat-Dx

With an intuitive workflow and the capability to process up to 48 targets utilizing real-time PCR technology, the QIAstat-Dx allows you to provide clinicians the answers that matter most.

The first assay to launch for the QIAstat-Dx is our respiratory panel which includes 21 targets for common pathogens causing acute respiratory tract infections. This panel utilizes powerful QIAGEN sample and assay technologies, to deliver true Sample to Insight processing of even the most challenging samples, including direct swab input.

If you want to learn more about and stay informed about the QIAstat-Dx, sign up below.

 

Get to know the QIAstat-Dx

 
 

Customer feedback on QIAstat-Dx at ECCMID 2018